Sign inGet started

Sham Hing

Insider CIK 1650158 · GBT Senior VP, Research

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
GBT Global Blood Therapeutics, M Exercise deriv2018-03-072018-03-0910,714— $010,715SEC↗
GBT Global Blood Therapeutics, M Exercise2018-03-072018-03-0910,714$0.49 $5.2K98,215SEC↗
GBT Global Blood Therapeutics, M Exercise deriv2018-02-142018-02-161,600— $05,600SEC↗
GBT Global Blood Therapeutics, F Tax w/h2018-02-142018-02-16553$62.30 $34.5K87,501SEC↗
GBT Global Blood Therapeutics, M Exercise2018-02-142018-02-161,600— $088,054SEC↗
GBT Global Blood Therapeutics, M Exercise deriv2018-02-012018-02-023,000— $018,000SEC↗
GBT Global Blood Therapeutics, A Award deriv2018-02-012018-02-0226,500— $026,500SEC↗
GBT Global Blood Therapeutics, A Award deriv2018-02-012018-02-0217,000— $017,000SEC↗
GBT Global Blood Therapeutics, F Tax w/h2018-02-012018-02-021,038$59.60 $61.9K86,454SEC↗
GBT Global Blood Therapeutics, M Exercise2018-02-012018-02-023,000— $087,492SEC↗
GBT Global Blood Therapeutics, M Exercise deriv2018-01-312018-02-021,600— $07,200SEC↗
GBT Global Blood Therapeutics, F Tax w/h2018-01-312018-02-02554$57.90 $32.1K84,492SEC↗
GBT Global Blood Therapeutics, M Exercise2018-01-312018-02-021,600— $085,046SEC↗
GBT Global Blood Therapeutics, M Exercise deriv2018-01-242018-01-261,600— $08,800SEC↗
GBT Global Blood Therapeutics, M Exercise2018-01-242018-01-261,600— $084,001SEC↗
GBT Global Blood Therapeutics, F Tax w/h2018-01-242018-01-26555$58.15 $32.3K83,446SEC↗
GBT Global Blood Therapeutics, M Exercise deriv2018-01-162018-01-181,600— $010,400SEC↗
GBT Global Blood Therapeutics, F Tax w/h2018-01-162018-01-18703$52.10 $36.6K82,401SEC↗
GBT Global Blood Therapeutics, M Exercise2018-01-162018-01-181,600— $083,104SEC↗
GBT Global Blood Therapeutics, A Award deriv2017-08-112017-08-1412,000— $012,000SEC↗
GBT Global Blood Therapeutics, M Exercise deriv2017-08-022017-08-0321,428— $021,429SEC↗
GBT Global Blood Therapeutics, M Exercise2017-08-022017-08-0321,428$0.49 $10.5K81,504SEC↗
GBT Global Blood Therapeutics, M Exercise deriv2017-08-012017-08-033,000— $021,000SEC↗
GBT Global Blood Therapeutics, F Tax w/h2017-08-012017-08-031,128$25.10 $28.3K60,076SEC↗
GBT Global Blood Therapeutics, M Exercise2017-08-012017-08-033,000— $061,204SEC↗
GBT Global Blood Therapeutics, A Award deriv2017-01-172017-01-1924,000— $024,000SEC↗
GBT Global Blood Therapeutics, A Award deriv2017-01-172017-01-1936,000— $036,000SEC↗
GBT Global Blood Therapeutics, A Award deriv2016-09-292016-10-037,858— $07,858SEC↗
GBT Global Blood Therapeutics, M Exercise deriv2016-08-012016-08-0321,429— $042,857SEC↗
GBT Global Blood Therapeutics, M Exercise2016-08-012016-08-0321,429$0.49 $10.5K58,204SEC↗
GBT Global Blood Therapeutics, A Award deriv2016-03-102016-03-147,857— $07,857SEC↗
GBT Global Blood Therapeutics, P Buy2015-08-172016-01-072,000$20.00 $40.0K36,775SEC↗
GBT Global Blood Therapeutics, M Exercise deriv2015-08-172015-08-194,062— $060,938SEC↗
GBT Global Blood Therapeutics, M Exercise deriv2015-08-172015-08-1921,428— $064,286SEC↗
GBT Global Blood Therapeutics, M Exercise2015-08-172015-08-194,062$3.40 $13.8K34,775SEC↗
GBT Global Blood Therapeutics, M Exercise2015-08-172015-08-1921,428$0.49 $10.5K30,713SEC↗